Dearborn Dan has filed 8 insider transactions across 1 company since October 2024.
Most recent transaction: a grant/award of 273696 shares of TuHURA Biosciences, Inc./NV ($HURA) on January 06, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 6, 2026 | TuHURA Biosciences, Inc./NV | $HURA | Dearborn Dan | Chief Financial Officer | A | Options (Right to Buy) | 273696 | $0.00 | 273,696.0000 | 51,258,085 | 9999.99% | 0.53% |
| Dec. 12, 2025 | TuHURA Biosciences, Inc./NV | $HURA | Dearborn Dan | Chief Financial Officer | A | Options (Right to Buy) | 1531367 | $0.00 | 1,531,367.0000 | 51,258,085 | 9999.99% | 2.99% |
| Nov. 12, 2024 | TuHURA Biosciences, Inc./NV | $HURA | Dearborn Dan | Chief Financial Officer | A | Options (Right to Buy) | 489848 | $0.00 | 489,848.0000 | 0 | 9999.99% | 0.00% |
| Oct. 18, 2024 | TuHURA Biosciences, Inc./NV | $HURA | Dearborn Dan | Chief Financial Officer | A | Options (Right to Buy) | 15744 | $0.00 | 15,744.0000 | 0 | 9999.99% | 0.00% |
| Oct. 18, 2024 | TuHURA Biosciences, Inc./NV | $HURA | Dearborn Dan | Chief Financial Officer | A | Options (Right to Buy) | 66658 | $0.00 | 66,658.0000 | 0 | 9999.99% | 0.00% |
| Oct. 18, 2024 | TuHURA Biosciences, Inc./NV | $HURA | Dearborn Dan | Chief Financial Officer | A | Options (Right to Buy) | 232570 | $0.00 | 232,570.0000 | 0 | 9999.99% | 0.00% |
| Oct. 18, 2024 | TuHURA Biosciences, Inc./NV | $HURA | Dearborn Dan | Chief Financial Officer | A | Options (Right to Buy) | 33991 | $0.00 | 33,991.0000 | 0 | 9999.99% | 0.00% |
| Oct. 18, 2024 | TuHURA Biosciences, Inc./NV | $HURA | Dearborn Dan | Chief Financial Officer | A | Options (Right to Buy) | 68438 | $0.00 | 68,438.0000 | 0 | 9999.99% | 0.00% |